<header id=058653>
Published Date: 2011-08-08 12:31:44 EDT
Subject: PRO/AH> Anthrax - USA: emergency use of doxycycline hyclate
Archive Number: 20110808.2407
</header>
<body id=058653>
ANTHRAX - USA: EMERGENCY USE OF DOXYCYCLINE HYCLATE
***************************************************

A ProMED-mail post
http://www.promedmail.org
ProMED-mail is a program of the
International Society for Infectious Diseases
http://www.isid.org

Date: Wed 27 Jul 2011
Source: CRYPTOME, Federal Register report [edited]
http://cryptome.org/0005/hhs072711.htm


Anthrax: emergency use of doxycycline hyclate
---------------------------------------------
Federal Register 2011; 76(144): 44926-7. From the Federal Register
Online via the Government Printing Office (http://www.gpo.gov) FR
Doc No: 2011-18937

Department of Health and Human Services (HHS)
Office of the Secretary

Renewal of declaration regarding emergency use of doxycycline hyclate
tablets accompanied by emergency use information and amendment to
include all oral formulations of doxycycline

Summary
-------
The secretary of Homeland Security determined on 23 Sep 2008 that
there is a significant potential for a domestic emergency involving a
heightened risk of attack with a specified biological, chemical,
radiological, or nuclear agent or agents -- in this case, _Bacillus
anthracis_. On the basis of this determination, the secretary of
Health and Human Services is renewing the 1 Oct 2008 declaration by
former secretary Michael O Leavitt of an emergency justifying the
authorization of emergency use of doxycycline hyclate tablets
accompanied by emergency use information subject to the terms of any
authorization issued by the commissioner of food and drugs under 21
USC 360bbb-3(a) and amending the declaration to include all oral
formulations of doxycycline accompanied by emergency use information
subject to the terms of any authorization issued by the commissioner
of food and drugs under 21 USC 360bbb-3(a). This notice is being
issued in accordance with section 564(b)(4) of the Federal Food, Drug,
and Cosmetic Act, 21 USC 360bbb-3(b)(4).

Dates: this notice and referenced HHS declaration are effective as of
20 Jul 2011.

For further information contact
Nicole Lurie, MD MSPH
Assistant Secretary for Preparedness and Response
Office of the Secretary
Department of Health and Human Services
200 Independence Avenue, SW
Washington, DC 20201
USA
Telephone (202) 205-2882 (this is not a toll free number).

Supplementary information
-------------------------
On 23 Sep 2008, former secretary of Homeland Security, Michael
Chertoff, determined that there is a significant potential for a
domestic emergency, involving a heightened risk of attack with a
specified biological, chemical, radiological, or nuclear agent or
agents -- in this case, _B. anthracis_ -- although there is no current
domestic emergency involving anthrax, no current heightened risk of an
anthrax attack, and no credible information indicating an imminent
threat of an attack involving _B. anthracis_. Pursuant to section
564(b) of the Federal Food, Drug, and Cosmetic Act, 21 USC.
360bbb-3(b), and on the basis of such determination, on 1 Oct 2008,
former secretary of Health and Human Services, Michael O Leavitt,
declared an emergency justifying the authorization of the emergency
use of doxycycline hyclate tablets accompanied by emergency use
information subject to the terms of any authorization issued under 21
USC 360bbb-3(a).\1\

\1\ Pursuant to section 564(b)(4) of the Federal Food, Drug, and
Cosmetic Act, notice of the determination by the secretary of Homeland
Security and the declaration by the secretary of Health and Human
Services was provided at 73 FR 58242 (6 Oct 2008).

Pursuant to section 564(b)(2)(B) of the Federal Food, Drug, and
Cosmetic Act, 21 USC 360bbb-3(b), and on the basis of secretary
Chertoff's 23 Sep 2008 determination, I hereby renew former Secretary
Leavitt's 1 Oct 2008 declaration of an emergency justifying the
authorization of the emergency use of doxycycline hyclate tablets
accompanied by emergency use information subject to the terms of any
authorization issued under 21 USC 360bbb-3(a) and amend the
declaration to justify the authorization of all oral formulations of
doxycycline accompanied by emergency use information subject to the
terms of any authorization issued under 21 USC 360bbb-3(a). I
previously renewed the declaration on 1 Oct 2009 and 1 Oct 2010.\2\ I
am issuing this notice in accordance with section 564(b)(4) of the
Federal Food, Drug, and Cosmetic Act, 21 USC 360bbb-3(b)(4).

\2\ Pursuant to section 564(b)(4) of the Federal Food, Drug, and
Cosmetic Act, notices of the renewal of the declaration of the
secretary of Health and Human Services were provided at 74 FR 51,279
(6 Oct 2009) and 75 FR 61,489 (5 Oct 2010).

Dated: 20 Jul 2011
Kathleen Sebelius
Secretary
FR Doc. 2011-18937 Filed 7-26-11; 8:45 am

--
communicated by:
ProMED-mail
<promed@promedmail.org>

[I am very glad to see this official recognition of doxycycline as it
is efficient, fast acting, and very cost effective. - Mod.MHJ]

.................................................mhj/mj/sh
</body>
